Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 31,581

Document Document Title
WO/2017/082574A1
The present invention relates to an organic compound represented by [chemical formula A] or [chemical formula B] and an organic light-emitting device comprising same.  
WO/2017/083297A1
A process for production of 2,5-furandicarboxylic acid (FDCA) is provided. The process comprises reacting a compound having a formula of R1OOC(CHOH)4COOR2, wherein R1 and R2 are selected from the group consisting of alkali metal, alkalin...  
WO/2017/083242A1
Compounds capable of inhibiting suppression of tumorgenicity 2 (ST2) are disclosed. The compounds are useful in the treatment of a variety of diseases and conditions, such as alleviation of graft-versus-host disease (GVHD), cardiovascula...  
WO/2017/078494A1
The present application provides: a heterocyclic compound capable of greatly improving the lifespan, efficiency, electrochemical stability and thermal stability of an organic light emitting device; and an organic light emitting device ha...  
WO/2017/079719A1
Disclosed are compounds of the Formula 1 wherein A is an aromatic moiety; H is a hydrophobic group comprising a main alkyl chain having from about 3 to about 26 carbon atoms and comprising a C2 or greater alkyl chain branched from the ma...  
WO/2017/079718A1
Methods that include acylating an aromatic containing compound by reacting the aromatic containing compound with an anhydride containing compound to form an acylated aromatic containing compound.  
WO/2017/076626A1
The invention relates to a novel method for converting a filler comprising at least one sugar into 5-hydroxymethylfurfural, in which said filler is brought into contact with at least one catalyst of the family of homogeneous sulfonic aci...  
WO/2017/076947A1
The invention relates to a process for preparing furan-2,5-dicarboxylic acid comprising the following steps: (a) preparing or providing a starting material mixture comprising 5-(hydroxymethyl)furfural (HMF) as a first reactant and one or...  
WO/2017/076625A1
The invention relates to a method for producing 5-hydroxymethylfurfural from a filler comprising at least one sugar, using a combination of at least one catalyst selected from the homogeneous Lewis acids, the heterogeneous Lewis acids an...  
WO/2017/076942A1
The present invention relates to a process for preparing a mixture comprising 5-(hydroxy- methyl)furfural (HMF) and one or more HMF esters of formula (I, the process comprising the following steps: (A-1) preparing or providing a starting...  
WO/2017/076956A1
The present invention relates to a process for preparing furan-2,5-dicarboxylic acid, the process comprising the following steps: (A-1) preparing or providing a starting mixture comprising one, two or more carbohydrate compounds selected...  
WO/2017/077552A1
A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein.  
WO/2017/075590A3
Methods for forming 2-bromo, 2-fluoro ribofuranose intermediates and 2-chloro, 2- fluoro ribofuranose intermediates for use in preparing antiviral nucleosides are disclosed. Methods for forming nucleosides, and nucleoside prodrugs, using...  
WO/2017/071791A1
The present invention relates to compounds comprising a heterocyclic group substituted with a fluoranthene group and a particular aromatic or heteroaromatic group. The compounds are suitable for use in electronic devices, in particular o...  
WO/2017/073933A1
The present specification provides a spiro-type compound of chemical formula 1 and an organic light emitting element comprising the same.  
WO/2017/070878A1
The present invention belongs to the field of natural pharmaceuticals and pharmaceutical chemistry, and relates to novel esterified amino acid derivatives of triptolide of general formulae I and II or a pharmaceutically acceptable adduct...  
WO/2017/069428A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. An organic electroluminescent device can have a good lifespan by using the organic electroluminescent ...  
WO/2017/068401A1
The present invention relates to a process for obtaining the compound (–)-13,14,15,16-tetranor-8α,12-labdanodiol from the plant Ageratina jocotepecana, the method comprising the steps of: a) obtaining a concentrated organic extract fr...  
WO/2017/068400A1
The present invention relates to a method for synthesising the compound (±)-ambroxide from the compound (±) 13,14,15,16-tetranor-8α,12-labdanodiol, the method comprising the steps of: a) dissolving the (±) 13,14,15,16-tetranor-8α,12...  
WO/2017/070012A1
Provided herein are compounds containing two redox centers including a chalcogen redox center of the formula: wherein: R1, R2, X1, X2, Y1, and m are as defined herein. Also provided herein are pharmaceutical composition of the present co...  
WO/2017/070084A1
The disclosed subject matter provides N- hydroxylsulfonamide derivative compounds of formulae (I), (II) or (III) as drawn below, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using ...  
WO/2017/069210A1
Provided is an organic electroluminescent element that has, in order, an anode, a hole injection layer, a hole transport layer, a light emission layer, and a cathode, wherein the hole transport layer includes a compound represented by fo...  
WO/2017/069442A1
The present invention relates to a composition for an organic optoelectronic element, containing: at least one first compound represented by formula 1; and at least one second compound represented by formula 2, to an organic optoelectron...  
WO/2017/066103A1
A series of novel amides showing broad pharmaceutical activity. Compounds described herein are effective as anticonvulsants, chemical countermeasures, and analgesics. Such compounds also show, neuroprotective/neuroreparative effects and ...  
WO/2017/064512A1
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preve...  
WO/2017/065980A1
Methods for preparing 1) a sugar-derived ester, 2) a glycol generated from reduction of the ester, and 3) polymers fabricated from polycondensation of the ester or glycol with various diamines and dicarboxylic acids are described. In par...  
WO/2017/064179A1
The present invention provides a process for the preparation of 1,4-butanediol and tetrahydrofuran said process comprising contacting furan with hydrogen and water in the presence of a supported catalytic composition comprising at least ...  
WO/2017/065415A1
The present invention relates to an organic light emitting diode capable of high efficiency- and low voltage-driving and having a reduced luminance reduction rate in a low grayscale area, and more specifically, to an organic light emitti...  
WO/2017/061788A1
The present specification relates to a spiro compound and an organic light-emitting device comprising same.  
WO/2017/061786A1
The present specification relates to a spiro compound and an organic light-emitting device comprising same.  
WO/2017/061865A1
Gamma-valerolactone (GVL) is prepared from a levulinic acid ester in a continuous process wherein a stream of the levulinic acid ester together with a gaseous stream of a hydrogen-containing gas is contacted with a hydrogenation catalyst...  
WO/2017/060922A4
The invention discloses aneco-friendly process for hydrogenation (alkenealkene, carbonyl compound and aromatic) and hydrodeoxygenation (methoxy phenols) of organic compound using hydrous ruthenium oxide (HRO) and its supported form as a ...  
WO/2017/060922A1
The invention discloses aneco-friendly process for hydrogenation (alkenealkene, carbonyl compound and aromatic) and hydrodeoxygenation (methoxy phenols) of organic compound using hydrous ruthenium oxide (HRO) and its supported form as a ...  
WO/2017/061785A1
The present specification relates to a spiro-type compound and an organic light emitting diode comprising same.  
WO/2017/061858A1
Process for the manufacture of an adipic acid product by a reduction of a tetrahydrofuran dicarboxylic acid compound, wherein the tetrahydrofuran dicarboxylic acid compound is contacted with hydrogen iodide at a temperature of at least 1...  
WO/2017/054524A1
Disclosed is a nematicide of trans structure containing a lactone ring, characterized in that the general structural formula I is as shown in (I). R1, R2, R3, R4 and R5 are selected from hydrogen, cyano, fluorine, chlorine, bromine, an a...  
WO/2017/058757A1
Uses of acyl-homoserine lactone compounds are described. In particular, uses of acyl-homoserine lactone compounds as anti-thrombotic agents, to inhibit platelets from becoming hypersensitive, and/or to prevent thrombosis, are described.  
WO/2017/058915A1
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, stereoisomer or prodrug thereof, wherein A, B R1, R2a, R2b...  
WO/2017/059102A1
Provided herein, inter alia, are compositions and methods useful for treating hvperproliferative diseases, including cancer and non-malignant hvperproliferative diseases.  
WO/2017/057460A1
Provided is a method for producing an organic compound, wherein the organic compound is an industrially useful compound, and a deodorization step, for removing from a reaction solution odorants that are generated in or remaining after a ...  
WO/2017/054523A1
Disclosed are a nematicide containing a lactone ring, and a preparation method and a use thereof, where the nematicide comprises hydrogen, cyano, fluorine, chlorine, bromine, an alkyl containing 1 to 4 carbon atoms, an alkoxy containing ...  
WO/2017/059303A1
Provided herein are vinylogous thioester compounds and methods for using the compounds.  
WO/2017/057360A1
The present invention addresses the problem of providing: a polyimide which is derived from a novel tetracarboxylic dianhydride, has both excellent solubility in various types of organic solvents and thermoplasticity and therefore has ex...  
WO/2017/059318A3
The present disclosure relates to scaphopetalone analogs, methods of making the analogs, and their medicinal uses.  
WO/2017/059318A2
The present disclosure relates to scaphopetalone analogs, methods of making the analogs, and their medicinal uses.  
WO/2017/059347A1
Chewing gum base which include polymer material, such as polyvinyl acetate, and at least one miscible plasticizer are provided. The base can also include at least one emulsifier. The present application provides for methods of making gum...  
WO/2017/052129A1
The present invention provides an organic electric device comprising a hole transport layer and an electron blocking layer capable of improving the luminous efficiency, stability and lifetime of the organic electric device, and an electr...  
WO/2017/052099A1
Disclosed are a compound represented by chemical formula 1, an organic electronic device including a first electrode, a second electrode, and an organic material layer between a first electrode and a second electrode, and an electronic d...  
WO/2017/050609A1
A compound of formula (I) for use in electrolyte compositions for electrochemical cells.  
WO/2017/049409A1
Disclosed are compounds of general formula (I) that promote readthrough of a premature termination codon (PTC) of an RNA molecule in a translation system, and their use, alone or in combination with other compounds, such as aminoglycosid...  

Matches 151 - 200 out of 31,581